Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications

Abstract

Obesity and vitamin D deficiency have both been recognized as major public health issues worldwide, and there is growing evidence that they are related, although the cause–effect relationship remains unclear. Could obesity be contributing to low circulating 25-hydroxyvitamin D concentrations? Alternatively, could low vitamin D status predispose to obesity? In this review, the relationship between low circulating 25-hydroxyvitamin D and obesity, and possible underlying reasons from both perspectives, is presented. One potential mechanism by which obesity could contribute to low serum 25-hydroxyvitamin D is adipose sequestration of vitamin D. On the other hand, adipose tissue has both the vitamin D receptor and the ability to synthesize 1,25-dihydroxyvitamin D, and there is evidence that vitamin D may regulate adipose tissue mass, differentiation and metabolism in ways that might contribute to obesity. Of particular interest, vitamin D deficiency is common both before and after bariatric surgery, and is often difficult to treat, particularly with the more malabsorptive procedures. Additional research is needed to elucidate the complex and multifaceted factors underlying the association between low circulating 25-hydroxyvitamin D and obesity, and to identify optimal treatment approaches in obese individuals and in bariatric surgical patients both before and after surgery.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Popkin BM . Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr 2010; 91: 284S–288S.

    Article  CAS  PubMed  Google Scholar 

  2. Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 2011; 96: 168–175.

    Article  CAS  PubMed  Google Scholar 

  3. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF . Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26: 573–580.

    Article  CAS  PubMed  Google Scholar 

  4. Yach D, Stuckler D, Brownell KD . Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62–66.

    Article  CAS  PubMed  Google Scholar 

  5. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK . Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008; 16: 2323–2330.

    Article  Google Scholar 

  6. Buchwald H, Oien DM . Metabolic/bariatric surgery Worldwide 2008. Obes Surg 2009; 19: 1605–1611.

    Article  PubMed  Google Scholar 

  7. Holick MF . Vitamin D deficiency. N Engl J Med 2007; 357: 266–281.

    Article  CAS  PubMed  Google Scholar 

  8. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine: Washington, DC, 2010.

    Google Scholar 

  9. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2010; 128: 1414–1424.

    Article  CAS  Google Scholar 

  10. Artaza JN, Mehrotra R, Norris KC . Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009; 4: 1515–1522.

    Article  CAS  PubMed  Google Scholar 

  11. Ozfirat Z, Chowdhury TA . Vitamin D deficiency and type 2 diabetes. Postgrad Med J 2010; 86: 18–25.

    Article  CAS  PubMed  Google Scholar 

  12. Foss YJ . Vitamin D deficiency is the cause of common obesity. Med Hypotheses 2009; 72: 314–321.

    Article  CAS  PubMed  Google Scholar 

  13. Osei K . 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab 2010; 95: 4220–4222.

    Article  CAS  PubMed  Google Scholar 

  14. Bischoff-Ferrari H . Health effects of vitamin D. Dermatol Ther 2010; 23: 23–30.

    Article  PubMed  Google Scholar 

  15. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888–894.

    CAS  PubMed  Google Scholar 

  16. Wood RJ . Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008; 66: 40–46.

    Article  PubMed  Google Scholar 

  17. Kamei Y, Kawada T, Kazuki R, Ono T, Kato S, Sugimoto E . Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1993; 193: 948–955.

    Article  CAS  PubMed  Google Scholar 

  18. Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D et al. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol 1999; 10: 2158–2164.

    Article  CAS  PubMed  Google Scholar 

  19. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK et al. 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008; 112: 122–126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Alemzadeh R, Kichler J, Babar G, Calhoun M . Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008; 57: 183–191.

    Article  CAS  PubMed  Google Scholar 

  21. Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, Levy S et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98–103.

    Article  PubMed  Google Scholar 

  22. Ernst B, Thurnheer M, Schmid SM, Schultes B . Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66–73.

    Article  PubMed  Google Scholar 

  23. Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E . Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006; 10: 1033–1037.

    Article  PubMed  Google Scholar 

  24. Jin J, Stellato TA, Hallowell PT, Schuster M, Graf K, Wilhelm S . Utilization of preoperative patient factors to predict postoperative vitamin D deficiency for patients undergoing gastric bypass. J Gastrointest Surg 2009; 13: 1052–1057.

    Article  PubMed  Google Scholar 

  25. Mahlay NF, Verka LG, Thomsen K, Merugu S, Salomone M . Vitamin D status before Roux-en-Y and efficacy of prophylactic and therapeutic doses of vitamin D in patients after Roux-en-Y gastric bypass surgery. Obes Surg 2009; 19: 590–594.

    Article  PubMed  Google Scholar 

  26. Stein EM, Strain G, Sinha N, Ortiz D, Pomp A, Dakin G et al. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol (Oxf) 2009; 71: 176–183.

    Article  CAS  Google Scholar 

  27. Signori C, Zalesin KC, Franklin B, Miller WL, McCullough PA . Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg 2010; 20: 949–952.

    Article  PubMed  Google Scholar 

  28. Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007; 30: 653–658.

    Article  CAS  PubMed  Google Scholar 

  29. Brock K, Huang WY, Fraser DR, Ke L, Tseng M, Stolzenberg-Solomon R et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 2010; 121: 462–466.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Aasheim E, Hofs D, Hjelmesaeth J, Birkeland K, Bhmer T . Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87: 362–369.

    Article  CAS  PubMed  Google Scholar 

  31. Chai W, Conroy S, Maskarinec G, Franke A, Pagano I, Cooney R . Associations between obesity and serum lipid-soluble micronutrients among premenopausal women. Nutr Res 2010; 30: 227–232.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251–4257.

    Article  CAS  PubMed  Google Scholar 

  33. Flores L, Osaba MJ, Andreu A, Moize V, Rodriguez L, Vidal J . Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg 2010; 20: 738–743.

    Article  PubMed  Google Scholar 

  34. Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R . Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)—a prospective study. Obesity Surg 2010; 20: 447–453.

    Article  Google Scholar 

  35. Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J et al. Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg 2008; 18: 145–150.

    Article  PubMed  Google Scholar 

  36. Granado-Lorencio F, Simal-Anton A, Salazar-Mosteiro J, Herrero-Barbudo C, Donoso-Navarro E, Blanco-Navarro I et al. Time-course changes in bone turnover markers and fat-soluble vitamins after obesity surgery. Obes Surg 2010; 20: 1524–1529.

    Article  PubMed  Google Scholar 

  37. Khandalavala BN, Hibma PP, Fang X . Prevalence and persistence of vitamin D deficiency in biliopancreatic diversion patients: a retrospective study. Obes Surg 2010; 20: 881–884.

    Article  PubMed  Google Scholar 

  38. Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J . Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res 2010; 164: 198–202.

    Article  CAS  PubMed  Google Scholar 

  39. Compher CW, Badellino KO, Boullata JI . Vitamin D and the bariatric surgical patient: a review. Obes Surg 2008; 18: 220–224.

    Article  PubMed  Google Scholar 

  40. Bischof MG, Heinze G, Vierhapper H . Vitamin D status and its relation to age and body mass index. Horm Res 2006; 66: 211–215.

    CAS  PubMed  Google Scholar 

  41. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD . Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 2010; 18: 1906–1910.

    Article  CAS  Google Scholar 

  43. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196–1199.

    Article  CAS  PubMed  Google Scholar 

  44. Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G . Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr 2010; 49: 401–407.

    Article  CAS  PubMed  Google Scholar 

  45. Vilarrasa N, Vendrell J, Maravall J, Elo I, Solano E, San Jos P et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 2010; 38: 235–242.

    Article  CAS  PubMed  Google Scholar 

  46. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin H et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009; 280: 559–563.

    Article  PubMed  Google Scholar 

  47. Kremer R, Campbell PP, Reinhardt T, Gilsanz V . Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 2009; 94: 67–73.

    Article  CAS  PubMed  Google Scholar 

  48. Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, Wang Y, Zonderman AB . Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 2010; 95: 3814–3827.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Valina-Toth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, Flack JM . Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 2010; 72: 595–603.

    Article  CAS  Google Scholar 

  50. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94: 3306–3313.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59: 242–248.

    Article  CAS  PubMed  Google Scholar 

  52. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010; 95: 1076–1083.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Yanoff LB, Parikh SJ, Spitalnik A, Denkinger B, Sebring NG, Slaughter P et al. The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) 2006; 64: 523–529.

    Article  CAS  Google Scholar 

  54. Winters SJ, Chennubhatla R, Wang C, Miller JJ . Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 2009; 58: 438–442.

    Article  CAS  PubMed  Google Scholar 

  55. Lips P . Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4–8.

    Article  CAS  PubMed  Google Scholar 

  56. Norman AW . From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S–499S.

    Article  CAS  PubMed  Google Scholar 

  57. Rueda S, Fernandez-Fernandez C, Romero F, Martinez de Osaba J, Vidal J . Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008; 18: 151–154.

    Article  PubMed  Google Scholar 

  58. Clements RH, Yellumahanthi K, Wesley M, Ballem N, Bland KI . Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass. Am Surg 2008; 74: 469–474.

    Article  PubMed  Google Scholar 

  59. Lagunova Z, Porojnicu AC, Vieth R, Lindberg FA, Hexeberg S, Moan J . Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr 2011; 141: 112–117.

    Article  CAS  PubMed  Google Scholar 

  60. Frost M, Abrahamsen B, Nielsen TL, Hagen C, Andersen M, Brixen K . Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism. Clin Endocrinol (Oxf) 2010; 73: 573–580.

    Article  CAS  Google Scholar 

  61. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R . Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008; 47: 87–91.

    Article  CAS  PubMed  Google Scholar 

  62. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690–693.

    Article  CAS  PubMed  Google Scholar 

  63. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J et al. Vitamin D(3) in fat tissue. Endocrine 2008; 33: 90–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Lin E, Armstrong-Moore D, Liang Z, Sweeney JF, Torres WE, Ziegler TR et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring) 2010; 19: 588–594.

    Article  CAS  Google Scholar 

  65. Aasheim ET, Bjorkman S, Sovik TT, Engstrom M, Hanvold SE, Mala T et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 2009; 90: 15–22.

    Article  PubMed  Google Scholar 

  66. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251–4257.

    Article  CAS  PubMed  Google Scholar 

  67. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517–524.

    Article  CAS  PubMed  Google Scholar 

  68. Kull M, Kallikorm R, Lember M . Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 2009; 39: 256–258.

    Article  CAS  PubMed  Google Scholar 

  69. Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S . Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 2007; 103: 679–681.

    Article  CAS  PubMed  Google Scholar 

  70. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C . Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007; 77: 47–57.

    Article  CAS  PubMed  Google Scholar 

  71. Compher C, Badellino KO . Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr 2008; 32: 645–647.

    Article  Google Scholar 

  72. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S . Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010–1013.

    Article  CAS  PubMed  Google Scholar 

  73. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94: 4023–4030.

    Article  CAS  PubMed  Google Scholar 

  74. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687–698.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Goransson LG, Omdal R . No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010; 50: 175–180.

    Article  CAS  PubMed  Google Scholar 

  76. Rayalam S, Della-Fera MA, Ambati S, Yang JY, Park HJ, Baile CA . Enhanced effects of 1,25(OH)(2)D(3) plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008; 16: 539–546.

    Article  CAS  Google Scholar 

  77. Kong J, Li YC . Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006; 290: E916–E924.

    Article  CAS  PubMed  Google Scholar 

  78. Vieth R . Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of ‘free’ 1,25-dihydroxyvitamin D. Clin Chem 1994; 40: 435–441.

    Article  CAS  PubMed  Google Scholar 

  79. Gonzales AM, Orlando RA . Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (Lond) 2007; 4: 22.

    Article  CAS  Google Scholar 

  80. Dani C, Amri EZ, Bertrand B, Enerback S, Bjursell G, Grimaldi P et al. Expression and regulation of pOb24 and lipoprotein lipase genes during adipose conversion. J Cell Biochem 1990; 43: 103–110.

    Article  CAS  PubMed  Google Scholar 

  81. Tontonoz P, Kim JB, Graves RA, Spiegelman BM . ADD1: a novel helix–loop–helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13: 4753–4759.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22: 2941–2952.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD et al. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 1989; 3: 1323–1335.

    Article  CAS  PubMed  Google Scholar 

  84. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM . mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224–1234.

    Article  CAS  PubMed  Google Scholar 

  85. Tontonoz P, Hu E, Spiegelman BM . Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147–1156.

    Article  CAS  PubMed  Google Scholar 

  86. Freytag SO, Geddes TJ . Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 1992; 256: 379–382.

    Article  CAS  PubMed  Google Scholar 

  87. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 2009; 296: E820–E828.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Boon N, Hul GB, Sicard A, Kole E, Van Den Berg ER, Viguerie N et al. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 2006; 14: 1739–1746.

    Article  CAS  Google Scholar 

  89. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance—a prospective randomized double-blind study. Acta Med Scand 1987; 222: 361–367.

    Article  CAS  PubMed  Google Scholar 

  90. Ortega RM, Lopez-Sobaler AM, Aparicio A, Bermejo LM, Rodriguez-Rodriguez E, Perea JM et al. Vitamin D status modification by two slightly hypocaloric diets in young overweight/obese women. Int J Vitam Nutr Res 2009; 79: 71–78.

    Article  CAS  PubMed  Google Scholar 

  91. Teegarden D, White KM, Lyle RM, Zemel MB, Van Loan MD, Matkovic V et al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 2008; 16: 1566–1572.

    Article  CAS  Google Scholar 

  92. Chan She Ping-Delfos W, Soares M . Diet induced thermogenesis, fat oxidation and food intake following sequential meals: Influence of calcium and vitamin D. Clinical Nutrition 2011; 30: 376–383.

    Article  CAS  Google Scholar 

  93. Sneve M, Figenschau Y, Jorde R . Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008; 159: 675–684.

    Article  CAS  PubMed  Google Scholar 

  94. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321–1327.

    Article  CAS  PubMed  Google Scholar 

  95. McCarty MF, Thomas CA . PTH excess may promote weight gain by impeding catecholamine-induced lipolysis—implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003; 61: 535–542.

    Article  CAS  PubMed  Google Scholar 

  96. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC . Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132–1138.

    Article  CAS  PubMed  Google Scholar 

  97. Zemel MB . Mechanisms of dairy modulation of adiposity. J Nutr 2003; 133: 252S–256S.

    Article  PubMed  Google Scholar 

  98. Holecki M, Zahorska-Markiewicz B, Wiecek A, Mizia-Stec K, Nieszporek T, Zak-Golab A . Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts 2008; 1: 274–279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Shahar D, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler G et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010; 92: 1017–1022.

    Article  CAS  PubMed  Google Scholar 

  100. Carlin AM, Rao DS, Yager KM, Genaw JA, Parikh NJ, Szymanski W . Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis 2006; 2: 638–642.

    Article  PubMed  Google Scholar 

  101. Gasteyger C, Suter M, Gaillard RC, Giusti V . Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 2008; 87: 1128–1133.

    Article  CAS  PubMed  Google Scholar 

  102. Madan AK, Orth WS, Tichansky DS, Ternovits CA . Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg 2006; 16: 603–606.

    Article  PubMed  Google Scholar 

  103. Pajecki D, Dalcanalle L, Souza de Oliveira CP, Zilberstein B, Halpern A, Garrido Jr AB et al. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg 2007; 17: 601–607.

    Article  PubMed  Google Scholar 

  104. Carlin AM, Yager KM, Rao DS . Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass. Am J Surg 2008; 195: 349–352.

    Article  CAS  PubMed  Google Scholar 

  105. Norman AW, Deluca HF . The preparation of H3-vitamins D2 and D3—their localization in the rat. Biochemistry 1963; 2: 1160–1168.

    Article  CAS  PubMed  Google Scholar 

  106. Schachter D, Finkelstein JD, Kowarski S . Metabolism of vitamin D. I. Preparation of radioactive vitamin D and its intestinal absorption in the rat. J Clin Invest 1964; 43: 787–796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Goldner WS, Stoner JA, Lyden E, Thompson J, Taylor K, Larson L et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg 2009; 19: 173–179.

    Article  PubMed  Google Scholar 

  108. Williams SE . Bariatric surgery and skeletal health. www.osteoporosissymptoms.org/cmexam/Issue19BariatricSurgery/bariatric.htm 2010.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C P Earthman.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Earthman, C., Beckman, L., Masodkar, K. et al. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes 36, 387–396 (2012). https://doi.org/10.1038/ijo.2011.119

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2011.119

Keywords

This article is cited by

Search

Quick links